Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 1,865

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Molecular, pharmacological and functional diversity of 5-HT receptors

Hoyer, Daniel, Hannon, Jason P, Martin, Graeme R·2002·Pharmacology Biochemistry and Behavior
DOI 10.1016/s0091-3057(01)00746-8
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0091-3057(01)00746-8

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 223

  1. Adham, 1998, Functional characterization of the recombinant human 5-hydroxytryptamine 7(a) receptor isoform coupled to adenylate cyclase stimulation, J Pharmacol Exp Ther, 287, 508
  2. Artigas, 2001, How does pindolol improve antidepressant action?, Trends Pharmacol Sci, 22, 224, 10.1016/S0165-6147(00)01682-5 · DOI · Paper page
  3. Ase, 2001, Regional changes in density of serotonin transporter in the brain of 5-HT1A and 5-HT1B knockout mice, and of serotonin innervation in the 5-HT1B knockout, J Neurochem, 78, 619, 10.1046/j.1471-4159.2001.00437.x · DOI
  4. Baker, 1998, Stimulation of type 1 and type 8 Ca2+/calmodulin-sensitive adenylyl cyclases by the Gs-coupled 5-hydroxytryptamine subtype 5-HT7A receptor, J Biol Chem, 273, 17469, 10.1074/jbc.273.28.17469 · DOI
  5. Bard, 1993, Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase, J Biol Chem, 268, 23422, 10.1016/S0021-9258(19)49479-9 · DOI · Paper page
  6. Barone, 1993, Quantitative autoradiography of 5-HT1E binding sites in rodent brains: effect of lesion of serotonergic neurons, Eur J Pharmacol, 249, 221, 10.1016/0014-2999(93)90436-L · DOI
  7. Barone, 1994, Quantitative autoradiography of 5-HT1D and 5-HT1E binding sites labelled by [3H]5-HT, in frontal cortex and the hippocampal region of the human brain, Brain Res, 638, 85, 10.1016/0006-8993(94)90636-X · DOI
  8. Beer, 1993, L 694247: a potent 5-HT1D receptor agonist, Br J Pharmacol, 110, 1196, 10.1111/j.1476-5381.1993.tb13941.x · DOI
  9. Bender, 2000, Structure of the human serotonin 5-HT4 receptor gene and cloning of a novel 5-HT4 splice variant, J Neurochem, 74, 478, 10.1046/j.1471-4159.2000.740478.x · DOI
  10. Bennett, 1976, Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors, Mol Pharmacol, 12, 373
  11. Bentue-Ferrer, 1998, 5-HT-moduline, a 5-HT1B/1D receptor endogenous modulator, interacts with dopamine release measured in vivo by microdialysis, Eur J Pharmacol, 358, 129, 10.1016/S0014-2999(98)00586-X · doi:10.1016/s0014-2999(98)00586-x
  12. Bervoets, 1993, 5-HT1A receptors and the tail-flick response. Spinally localized 5-HT1A receptors postsynaptic to serotoninergic neurons mediate spontaneous tail-flicks in the rat, J Pharmacol Exp Ther, 264, 95
  13. Bickerdike, 1999, 5-HT2C receptor modulation and the treatment of obesity, Diabetes, Obes Metab, 1, 207, 10.1046/j.1463-1326.1999.00037.x · DOI
  14. Bill, 1991, Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia, Br J Pharmacol, 103, 1857, 10.1111/j.1476-5381.1991.tb12342.x · DOI · Paper page
  15. Blondel, 1997, Molecular and functional characterization of a 5-HT4 receptor cloned from human atrium, FEBS Lett, 412, 465, 10.1016/S0014-5793(97)00820-X · DOI
  16. Blondel, 1998, Cloning, expression and pharmacology of four human 5-hydroxy tryptamine 4 receptor isoforms produced by alternative splicing in the carboxyl terminus, J Neurochem, 70, 2252, 10.1046/j.1471-4159.1998.70062252.x · DOI · Paper page
  17. Bockaert, 1992, The 5-HT4 receptor: a place in the sun, Trends Pharmacol Sci, 13, 141, 10.1016/0165-6147(92)90051-7 · DOI · Paper page
  18. Boess, 1994, Molecular biology of 5-HT receptors, Neuropharmacology, 33, 275, 10.1016/0028-3908(94)90059-0 · DOI · Paper page
  19. Boess, 1995, Ultrastructure of the 5-hydroxytryptamine 3 receptor, J Neurochem, 64, 1401, 10.1046/j.1471-4159.1995.64031401.x · DOI
  20. Boger, 2000, Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide, Proc Natl Acad Sci U S A, 97, 5044, 10.1073/pnas.97.10.5044 · DOI · Paper page
  21. Bonhaus, 1994, [3H]RS-23597-190, a potent 5-hydroxytryptamine4 antagonist labels sigma-1 but not sigma-2 binding sites in guinea pig brain, J Pharmacol Exp Ther, 271, 484
  22. Bonhaus, 1997, RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist, Neuropharmacology, 36, 621, 10.1016/S0028-3908(97)00049-X · DOI
  23. Bonhaus, 1999, RS-127445: a selective, high affinity, orally bioavailable 5-HT2B receptor antagonist, Br J Pharmacol, 127, 1075, 10.1038/sj.bjp.0702632 · DOI
  24. Bonnin, 1999, Acute stress induces a differential increase of 5-HT-moduline (LSAL) tissue content in various rat brain areas, Brain Res, 825, 152, 10.1016/S0006-8993(99)01265-2 · DOI
  25. Bos, 2001, 5-HT6 receptor antagonists: lead-optimization and biological evaluation of N-aryl and N-heteroaryl 4-amino-benzene sulfonamides, Eur J Med Chem, 36, 165, 10.1016/S0223-5234(00)01209-5 · doi:10.1016/s0223-5234(00)01209-5
  26. Bourin, 2001, Drug mechanisms in anxiety, Curr Opin Invest Drugs, 2, 259
  27. Bourson, 1995, Determination of the role of the 5-ht6 receptor in the rat brain: a study using antisense oligonucleotides, J Pharmacol Exp Ther, 274, 173
  28. Boyd, 1994, Urinary disorders associated with cisapride. Adverse Drug Reactions Advisory Committee, Med J Aust, 160, 579, 10.5694/j.1326-5377.1994.tb138353.x · doi:10.5694/j.1326-5377.1994.tb138353.x
  29. Bradley, 1986, Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine, Neuropharmacology, 25, 563, 10.1016/0028-3908(86)90207-8 · DOI · Paper page
  30. Branchek, 1997, Molecular biology and potential functional role of 5-HT5, 5-HT6, and 5-HT7 receptors, Handb Exp Pharmacol, 129, 475, 10.1007/978-3-642-60921-3_18 · DOI
  31. Branchek, 2000, 5-ht6 receptors as emerging targets for drug discovery, Annu Rev Pharmacol Toxicol, 40, 319, 10.1146/annurev.pharmtox.40.1.319 · DOI
  32. Bromidge, 1999, 5-chloro-N-(4-methoxy-3-piperazin-1-yl-phenyl)-3-methyl-2-benzothiophenesulfonamide (SB-271046): A Potent, Selective, and Orally Bioavailable 5-HT6 Receptor Antagonist, Med Chem, 42, 202, 10.1021/jm980532e · doi:10.1021/jm980532e
  33. Bromidge, 2001, Phenyl benzenesulfonamides are novel and selective 5-HT6 antagonists: identification of N-(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-piperazin-1-ylbenzenesulfonamide (SB-357134), Bioorg Med Chem Lett, 11, 55, 10.1016/S0960-894X(00)00597-7 · doi:10.1016/s0960-894x(00)00597-7
  34. Bruinvels, 1991, Homogeneous 5-HT1D recognition sites in the human substantia nigra identified with a new iodinated radioligand, Eur J Pharmacol, 202, 89, 10.1016/0014-2999(91)90257-Q · doi:10.1016/0014-2999(91)90257-q
  35. Bruinvels, 1994, Localization of 5-HT1B, 5-HT1Dα, 5-HT1E and 5-HT1F receptor mRNA in rodent and primate brain, Neuropharmacology, 33, 367, 10.1016/0028-3908(94)90067-1 · DOI · Paper page
  36. Buchheit, 1986, The rat isolated stomach fundus strip, a model for 5-HT1C receptors, Br J Pharmacol, 88, 367P
  37. Buchheit, 1995, The serotonin 5-HT4 receptor: Part 2. Structure activity studies of the indolecarbazimidamide agonist, J Med Chem, 38, 2331, 10.1021/jm00013a010 · DOI
  38. Buhlen, 1996, Evidence for presynaptic location of inhibitory 5-HT1D beta-like autoreceptors in the guinea-pig brain cortex, Naunyn-Schmiedeberg's Arch Pharmacol, 353, 281, 10.1007/BF00168629 · doi:10.1007/bf00168629
  39. Camilleri, 2001, Tegaserod, Aliment Pharmacol Ther, 15, 277, 10.1046/j.1365-2036.2001.00925.x · DOI
  40. Carson, 1996, The 5-HT5A serotonin receptor is expressed predominantly by astrocytes in which it inhibits cAMP accumulation: a mechanism for neuronal suppression of reactive astrocytes, Glia, 17, 317, 10.1002/(SICI)1098-1136(199608)17:4<317::AID-GLIA6>3.0.CO;2-W · DOI
  41. Carter, 1995, Characterization of a postjunctional 5-HT receptor mediating relaxation of guinea-pig isolated ileum, Eur J Pharmacol, 280, 243, 10.1016/0014-2999(95)00195-Q · DOI
  42. Castro, 1997, Identification and characterisation of a new serotonergic recognition site with high affinity for 5-carboxamidotryptamine in mammalian brain, J Neurochem, 69, 2123, 10.1046/j.1471-4159.1997.69052123.x · doi:10.1046/j.1471-4159.1997.69052123.x
  43. Cheetham, 1993, Evidence that RU 24969-induced locomotor activity in C57/B1/6 mice is specifically mediated by the 5-HT1B receptor, Br J Pharmacol, 110, 1621, 10.1111/j.1476-5381.1993.tb14010.x · DOI
  44. Claeysen, 1997, Cloning and expression of human 5-HT4S receptors. Effect of receptor density on their coupling to adenylyl cyclase, NeuroReport, 8, 3189, 10.1097/00001756-199710200-00002 · doi:10.1097/00001756-199710200-00002
  45. Claeysen, 1999, Novel brain-specific 5-HT4 receptor splice variants show marked constitutive activity: role of the C-terminal intracellular domain, Mol Pharmacol, 55, 910
  46. Clarke, 1989, The 5-HT4 receptor: naughty but nice, Trends Pharmacol Sci, 10, 385, 10.1016/0165-6147(89)90177-6 · DOI · Paper page
  47. Clemett, 1999, Pindolol-insensitive [3H]-5-hydroxytryptamine binding in the rat hypothalamus; identity with 5-hydroxytryptamine7 receptors, Br J Pharmacol, 127, 236, 10.1038/sj.bjp.0702503 · doi:10.1038/sj.bjp.0702503
  48. Clineschmidt, 1985, Characterisation of 5-Hydroxytryptamine receptors in rat stomach fundus, J Pharmacol Exp Ther, 243, 264
  49. Cloez-Tayarani, 1997, Autoradiographic characterization of [3H]-5-HT-moduline binding sites in rodent brain and their relationship to 5-HT1B receptors, Proc Nat Acad Sci U S A, 94, 9899, 10.1073/pnas.94.18.9899 · DOI
  50. Cloez-Tayarani, 1998, Mapping of 5-HT-moduline binding sites in guinea-pig brain by film and digital autoradiography, Brain Res, 798, 311, 10.1016/S0006-8993(98)00393-X · doi:10.1016/s0006-8993(98)00393-x
  51. Cohen, 1986, Further evidence that the serotonin receptor in the rat stomach fundus is not 5-HT1A or 5-HT1B, Life Sci, 38, 1, 10.1016/0024-3205(86)90267-5 · doi:10.1016/0024-3205(86)90267-5
  52. Conner, 1990, Serotonin receptor-mediated activation of adenylate cyclase in the neuroblastoma NCB 20: a novel 5-hydroxytryptamine receptor, Mol Pharmacol, 37, 742
  53. Cox, 1996, 5-HT2B receptor signaling in the rat stomach fundus: dependence on calcium influx, calcium release and protein kinase C, Behav Brain Res, 73, 289, 10.1016/0166-4328(96)00125-8 · DOI
  54. Crabbe, 1996, Elevated alcohol consumption in null mutant mice lacking 5-HT1B, Nat Genet, 14, 98, 10.1038/ng0996-98 · DOI · Paper page
  55. Crabbe, 1999, Genetics of mouse behaviour: interactions with laboratory environment, Science, 284, 670, 10.1126/science.284.5420.1670 · DOI · Paper page
  56. Cutrer, 1999, Effects of PNU 109291, a selective 5-HT1D receptor agonist, on electrically induced dural plasma extravasation and capsaicin-evoked c-fos immunoreactivity within trigeminal nucleus caudalis, Neuropharmacology, 38, 1043, 10.1016/S0028-3908(99)00032-5 · DOI
  57. Davies, 1999, The 5-HT3B subunit is a major determinant of serotonin-receptor function, Nature, 397, 359, 10.1038/16941 · DOI · Paper page
  58. Day, 1963, An analysis of the direct and indirect actions of drugs on the isolated guinea pig ileum, Br J Pharmacol, 20, 150
  59. De Koning, 1994, Eltoprazine in aggressive mentally handicapped patients: a double-blind, placebo- and baseline-controlled multi-centre study, Int Clin Psychopharmacol, 9, 187, 10.1097/00004850-199409000-00007 · DOI
  60. De Ponti, 2001, Irritable bowel syndrome: new agents targeting serotonin receptor subtypes, Drugs, 61, 317, 10.2165/00003495-200161030-00001 · DOI
  61. Dekeyne, 1999, Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist Ro 60-0175: a pharmacological analysis, Neuropharmacology, 38, 415, 10.1016/S0028-3908(98)00203-2 · DOI
  62. Den Boer, 2000, Serotonergic drugs in the treatment of depressive and anxiety disorders, Hum Psychopharmacol, 15, 315, 10.1002/1099-1077(200007)15:5<315::AID-HUP204>3.0.CO;2-Y · DOI
  63. Domenech, 1997, Characterization of human serotonin 1D and 1B receptors using [3H]-GR-125743, a novel radiolabeled serotonin 5HT1D/1B receptor antagonist, Naunyn-Schmiedeberg's Arch Pharmacol, 356, 328, 10.1007/PL00005058 · DOI
  64. Dreteler, 1991, Systemic and regional Haemodynamic effects of the 5-hydroxytryptamine 1A receptor agonists flesinoxan and 8-hydroxy-2(di-N-propylamino)tetralin in the conscious rat, J Cardiovasc Pharmacol, 17, 488, 10.1097/00005344-199103000-00019 · doi:10.1097/00005344-199103000-00019
  65. Dubin, 1999, The pharmacological and functional characteristics of the serotonin 5-HT3A receptor are specifically modified by a 5-HT3B receptor subunit, J Biol Chem, 274, 30799, 10.1074/jbc.274.43.30799 · DOI · Paper page
  66. Dubin, 2001, Protein and cDNA sequences of a human subunit 5-HT3C of the 5-HT3 serotonin receptor and uses thereof, PCT Int Appl, 80
  67. Duxon, 1997, Evidence for expression of the 5-hydroxytryptamine 2B receptor protein in the rat central nervous system, Neuroscience (Oxford), 76, 323, 10.1016/S0306-4522(96)00480-0 · DOI · Paper page
  68. Duxon, 1997, Activation of 5-HT2B receptors in the medial amygdala causes anxiolysis in the social interaction test in the rat, Neuropharmacology, 36, 601, 10.1016/S0028-3908(97)00042-7 · DOI
  69. Eglen, 1997, 5-Hydroxytryptamine (5-HT)4 receptors and central nervous system function: an update, Prog Drug Res, 49, 9
  70. Erlander, 1993, Two members of a distinct subfamily of 5-hydroxytryptamine receptors differentially expressed in rat brain, Proc Natl Acad Sci U S A, 90, 3452, 10.1073/pnas.90.8.3452 · DOI · Paper page
  71. Errico, 2001, 5-HT7 receptors activate the mitogen activated protein kinase extracellular signal related kinase in cultured rat hippocampal neurons, Neuroscience (Oxford), 102, 361, 10.1016/S0306-4522(00)00460-7 · DOI
  72. Fargin, 1988, The genomic clone G-21 which resembles a β-adrenergic receptor sequence encodes the 5-HT1A receptor, Nature, 335, 358, 10.1038/335358a0 · DOI · Paper page
  73. Feniuk, 1983, 5-Hydroxytryptamine-induced relaxation of isolated mammalian smooth muscle, Eur J Pharmacol, 96, 71, 10.1016/0014-2999(83)90530-7 · doi:10.1016/0014-2999(83)90530-7
  74. Fillion, 2000, Potential of 5-HT-moduline as a drug target for affective disorders, Curr Opin Invest Drugs, 1, 104
  75. Fillion, 1996, A new peptide, 5-HT-moduline, isolated and purified from mammalian brain specifically interacts with 5-HT1B/1D receptors, Behav Brain Res, 73, 313, 10.1016/0166-4328(96)00120-9 · doi:10.1016/0166-4328(96)00120-9
  76. Fiorella, 1995, The interactions of typical and atypical antipsychotics with the (−)2,5,-dimethoxy-4-methamphetamine (DOM) discriminative stimulus, Neuropharmacology, 34, 1297, 10.1016/0028-3908(95)00101-B · DOI
  77. Fiorella, 1995, Role of 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs: II. Reassessment of LSD false positives, Psychopharmacology, 121, 357, 10.1007/BF02246075 · DOI
  78. Fitzgerald, 1999, Messenger RNA editing of the human serotonin 5-HT2C receptor, Neuropsychopharmacology, 21, 82S, 10.1038/sj.npp.1395328 · DOI
  79. Fitzgerald, 2000, Possible role of valvular serotonin 5-HT2B receptors in the cardiopathy associated with fenfluramine, Mol Pharmacol, 57, 75
  80. Fletcher, 1996, Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist, Behav Brain Res, 73, 337, 10.1016/0166-4328(96)00118-0 · DOI · Paper page
  81. Fone, 1989, Involvement of 5-HT2 receptors in the behaviors produced by intrathecal administration of selected 5-HT agonists and the TRH analog (CG 3509) to rats, Br J Pharmacol, 96, 599, 10.1111/j.1476-5381.1989.tb11858.x · doi:10.1111/j.1476-5381.1989.tb11858.x
  82. Forster, 1995, A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY 100635, Eur J Pharmacol, 281, 81, 10.1016/0014-2999(95)00234-C · DOI · Paper page
  83. Francken, 1998, The human 5-ht5A receptor couples to Gi/Go proteins and inhibits adenylate cyclase in HEK-293 cells, Eur J Pharmacol, 361, 299, 10.1016/S0014-2999(98)00744-4 · DOI
  84. Francken, 2000, Human 5-hydroxytryptamine 5A receptors activate coexpressed Gi and Go proteins in Spodoptera frugiperda-9 cells, Mol Pharmacol, 57, 1034
  85. Gaddum, 1957, Two kinds of tryptamine receptor, Br J Pharmacol Chemother, 12, 323, 10.1111/j.1476-5381.1957.tb00142.x · DOI · Paper page
  86. Gaster, 1998, The selective 5-HT1B receptor inverse agonist 1′-methyl-5-[[2′-methyl-4′-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4′-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo, J Med Chem, 41, 1218, 10.1021/jm970457s · DOI
  87. George, 2000, Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties, J Biol Chem, 275, 26128, 10.1074/jbc.M000345200 · DOI · Paper page
  88. Gerald, 1995, The 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variants, EMBO J, 14, 2806, 10.1002/j.1460-2075.1995.tb07280.x · DOI · Paper page
  89. Gershon, 1999, Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel, Aliment Pharmacol Ther, 13, 15, 10.1046/j.1365-2036.1999.00002.x-i2 · DOI · Paper page
  90. Glennon, 2000, 2-Substituted tryptamines: agents with selectivity for 5-HT6 serotonin receptors, J Med Chem, 43, 1011, 10.1021/jm990550b · DOI
  91. Grimaldi, 1997, Immunocytochemical localization of neurons expressing 5-HT-moduline in the mouse brain, Neuropharmacology, 36, 1079, 10.1016/S0028-3908(97)00099-3 · doi:10.1016/s0028-3908(97)00099-3
  92. Grimaldi, 1999, 5-Hydroxytryptamine-moduline: a novel endogenous peptide involved in the control of anxiety, Neuroscience, 93, 1223, 10.1016/S0306-4522(99)00322-X · doi:10.1016/s0306-4522(99)00322-x
  93. Gustafson, 1996, A receptor autoradiographic and in situ hybridization analysis of the distribution of the 5-ht7 receptor in rat brain, Br J Pharmacol, 117, 657, 10.1111/j.1476-5381.1996.tb15241.x · DOI · Paper page
  94. Hagan, 2000, Characterization of SB-269970-A, a selective 5-HT7 receptor antagonist, Br J Pharmacol, 130, 539, 10.1038/sj.bjp.0703357 · DOI · Paper page
  95. Hamon, 2000, The role of serotonin and other neuroactive molecules in the physiopathogenesis of migraine: current hypotheses, Pathol Biol, 48, 619
  96. Hanna, 2000, Evidence for expression of heteromeric serotonin 5-HT3 receptors in rodents, J Neurochem, 75, 240, 10.1046/j.1471-4159.2000.0750240.x · DOI
  97. Hartig, 1992, A subfamily of 5-HT1D receptor genes, Trends Pharmacol Sci, 13, 152, 10.1016/0165-6147(92)90053-9 · DOI · Paper page
  98. Hartig, 1996, Alignment of receptor nomenclature with the human genome. Effects on classification of 5-HT1D/5-HT1B receptor subtypes, Trends Pharmacol Sci, 17, 103, 10.1016/0165-6147(96)30002-3 · DOI · Paper page
  99. Hedlund, 1999, Allosteric regulation by oleamide of the binding properties of 5-hydroxytryptamine 7 receptors, Biochem Pharmacol, 58, 1807, 10.1016/S0006-2952(99)00274-9 · DOI
  100. Hegde, 1996, Peripheral 5-HT4 receptors, FASEB J, 10, 1398, 10.1096/fasebj.10.12.8903510 · DOI · Paper page
  101. Heidmann, 1997, Four 5-hydroxytryptamine 7 (5-HT7) receptor isoforms in human and rat produced by alternative splicing: species differences due to altered intron-exon organization, J Neurochem, 68, 1372, 10.1046/j.1471-4159.1997.68041372.x · DOI
  102. Heidmann, 1998, Function and distribution of three rat 5-hydroxytryptamine7 (5-HT7) receptor isoforms produced by alternative splicing, Neuropharmacology, 37, 1621, 10.1016/S0028-3908(98)00070-7 · DOI
  103. Heisler, 1998, Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice, Proc Natl Acad Sci U S A, 95, 15049, 10.1073/pnas.95.25.15049 · DOI · Paper page
  104. Herrick-Davis, 1999, Serotonin 5-HT2C receptor RNA editing alters receptor basal activity: implications for serotonergic signal transduction, J Neurochem, 73, 1711, 10.1046/j.1471-4159.1999.731711.x · DOI · Paper page
  105. Hirst, 2000, Characterization of [125I]-SB-258585 binding to human recombinant and native 5-HT6 receptors in rat, pig and human brain tissue, Br J Pharmacol, 130, 1597, 10.1038/sj.bjp.0703458 · DOI
  106. Hope, 1993, Cloning and functional expression of an apparent splice variant of the murine 5-HT3 receptor A subunit, Eur J Pharmacol, Mol Pharmacol Sect, 245, 187, 10.1016/0922-4106(93)90128-V · doi:10.1016/0922-4106(93)90128-v
  107. Hopwood, 2001, Multiple 5-HT1 autoreceptor subtypes govern serotonin release in dorsal and median raphe nuclei, Neuropharmacology, 40, 508, 10.1016/S0028-3908(00)00192-1 · DOI
  108. Hou, 2001, 5-HT1B and 5-HT1D receptors in the human trigeminal ganglion: co-localization with calcitonin gene-related peptide, substance P and nitric oxide synthase, Brain Res, 909, 112, 10.1016/S0006-8993(01)02645-2 · DOI
  109. Hoyer, 1988, Molecular pharmacology and biology of 5-HT1C receptors, Trends Pharmacol Sci, 9, 89, 10.1016/0165-6147(88)90174-5 · DOI · Paper page
  110. Hoyer, 1990, 5-HT3, 5-HT4 and 5-HT-M receptors, Neuropsychopharmacology, 3, 371
  111. Hoyer, 1997, 5-HT receptor classification and nomenclature: towards a harmonization with the human genome, Neuropharmacology, 36, 419, 10.1016/S0028-3908(97)00036-1 · DOI · Paper page
  112. Hoyer, 1989, Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain, Trends Pharmacol Sci, 10, 130, 10.1016/0165-6147(89)90159-4 · DOI · Paper page
  113. Hoyer, 1985, Characterization of the 5-HT1B recognition site in rat brain: binding studies with [125I]iodocyanopindolol, Eur J Pharmacol, 118, 1, 10.1016/0014-2999(85)90657-0 · DOI · Paper page
  114. Hoyer, 1985, Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (−)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin, Eur J Pharmacol, 118, 13, 10.1016/0014-2999(85)90658-2 · DOI · Paper page
  115. Hoyer, 1994, International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin), Pharmacol Rev, 46, 157
  116. Humphrey, 1993, A new nomenclature for 5-HT receptors, Trends Pharmacol Sci, 14, 233, 10.1016/0165-6147(93)90016-D · DOI · Paper page
  117. Jasper, 1997, Cloning, expression and pharmacology of a truncated splice variant of the human 5-HT7 receptor (h5-HT7b), Br J Pharmacol, 122, 126, 10.1038/sj.bjp.0701336 · DOI
  118. Jerman, 2001, Pharmacological characterisation of human 5-HT2 receptor subtypes, Eur J Pharmacol, 414, 23, 10.1016/S0014-2999(01)00775-0 · DOI
  119. Johnson, 1997, 5-HT1F receptor agonists inhibit neurogenic dural inflammation in guinea pigs, NeuroReport, 8, 2237, 10.1097/00001756-199707070-00029 · DOI
  120. Jorgensen, 1999, Adrenocorticotropic hormone secretion in rats induced by stimulation with serotonergic compounds, J Neuroendocrinol, 11, 283, 10.1046/j.1365-2826.1999.00328.x · doi:10.1046/j.1365-2826.1999.00328.x
  121. Jorgensen, 2001, Differential effect of serotonin 5-HT1A receptor antagonists on the secretion of corticotropin and prolactin, Neuroendocrinology, 73, 322, 10.1159/000054649 · DOI
  122. Kalkman, 1995, RU 24969-induced locomotion in rats is mediated by 5-HT1A receptors, Naunyn-Schmiedeberg's Arch Pharmacol, 352, 583, 10.1007/BF00169395 · doi:10.1007/bf00169395
  123. Kaumann, 1994, 5-Hydroxytryptamine causes rate-dependent arrhythmias through 5-HT4 receptors in human atrium: facilitation by chronic β-adrenoceptor blockade, Naunyn-Schmiedeberg's Arch Pharmacol, 349, 331, 10.1007/BF00170877 · doi:10.1007/bf00170877
  124. Kawahara, 1994, Inhibition by 5-HT7 receptor stimulation of GABAA receptor-activated current in cultured rat suprachiasmatic neurons, J Physiol (London), 478, 67, 10.1113/jphysiol.1994.sp020230 · DOI
  125. Kennett, 1994, In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist, Br J Pharmacol, 111, 797, 10.1111/j.1476-5381.1994.tb14808.x · DOI · Paper page
  126. Kennett, 1996, In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties, Br J Pharmacol, 117, 427, 10.1111/j.1476-5381.1996.tb15208.x · DOI · Paper page
  127. Kennett, 1997, BW 723C86, a 5-HT2B receptor agonist, causes hyperphagia and reduced grooming in rats, Neuropharmacology, 36, 233, 10.1016/S0028-3908(96)00171-2 · DOI
  128. Kennett, 1997, SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist, Neuropharmacology, 36, 609, 10.1016/S0028-3908(97)00038-5 · DOI · Paper page
  129. Kohen, 1996, Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor, J Neurochem, 66, 47, 10.1046/j.1471-4159.1996.66010047.x · DOI · Paper page
  130. Kursar, 1992, Molecular cloning, functional expression, and pharmacological characterization of a novel serotonin receptor (5-hydroxytryptamine2F) from rat stomach fundus, Mol Pharmacol, 42, 549
  131. Larsson, 1990, Different effects on the responses of functional pre- and postsynaptic 5-HT1A receptors by repeated treatment of rats with the 5-HT1A receptor agonist 8-OH-DPAT, Neuropharmacology, 29, 86, 10.1016/0028-3908(90)90047-U · DOI · Paper page
  132. Lee, 2000, Oligomerization of dopamine and serotonin receptors, Neuropsychopharmacology, 23, S32, 10.1016/S0893-133X(00)00155-X · DOI
  133. Lee, 2001, Orphan G protein-coupled receptors in the CNS, Curr Opin Pharmacol, 1, 31, 10.1016/S1471-4892(01)00003-0 · DOI
  134. Lewis, 1960, The inhibition by morphine of the action of smooth muscle stimulants on the guinea-pig intestine, Br J Pharmacol Chemother, 15, 425, 10.1111/j.1476-5381.1960.tb01267.x · doi:10.1111/j.1476-5381.1960.tb01267.x
  135. Leysen, 1996, Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D-alpha, human 5-hydroxytryptamine1D-beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan, Mol Pharmacol, 50, 1567
  136. Lovell, 2000, A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl) pyrrolidine-1-sulfonyl) phenol (SB-269970), J Med Chem, 43, 342, 10.1021/jm991151j · DOI · Paper page
  137. Lovenberg, 1993, A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms, Neuron, 11, 449, 10.1016/0896-6273(93)90149-L · DOI · Paper page
  138. Lucki, 1992, 5-HT1 receptors and behavior, Neurosci Biobehav Rev, 16, 83, 10.1016/S0149-7634(05)80055-7 · DOI
  139. Maricq, 1991, Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel, Science, 254, 432, 10.1126/science.1718042 · DOI · Paper page
  140. Martin, 1994, Receptors for 5-hydroxytryptamine: current perspectives on classification and nomenclature, Neuropharmacology, 33, 261, 10.1016/0028-3908(94)90058-2 · DOI · Paper page
  141. Martin, 1998, 5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential, J Pharmacol Exp Ther, 286, 913
  142. Martin, 1999, Electrophysiological comparison of 5-hydroxytryptamine1A receptor antagonists on dorsal raphe cell firing, J Pharmacol Exp Ther, 288, 820
  143. Massot, 1996, 5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors, Mol Pharmacol, 50, 752
  144. Matthes, 1993, Mouse 5-hydroxytryptamine 5A and 5-hydroxytryptamine 5B receptors define a new family of serotonin receptors: cloning, functional expression, and chromosomal localization, Mol Pharmacol, 43, 313
  145. Mayorga, 2001, Antidepressant-like behavioral effects in 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptor mutant mice, J Pharmacol Exp Ther, 298, 1101
  146. McCall, 1994, Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine 1A agonist, J Pharmacol Exp Ther, 271, 875
  147. McKune, 2001, Characterization of the serotonin receptor mediating contraction in the mouse thoracic aorta and signal pathway coupling, J Pharmacol Exp Ther, 297, 88
  148. Mehta, 2001, Increased mCPP-induced oral dyskinesia after lesion of serotonergic neurons, Pharmacol, Biochem Behav, 68, 347, 10.1016/S0091-3057(00)00476-7 · DOI
  149. Meneses, 2001, Effects of the 5-ht6 receptor antagonist Ro 04-6790 on learning consolidation, Behav Brain Res, 118, 107, 10.1016/S0166-4328(00)00316-8 · DOI
  150. Mialet, 2000, Isolation of the serotoninergic 5-HT4e receptor from human heart and comparative analysis of its pharmacological profile in C6-glial and CHO cell lines, Br J Pharmacol, 129, 771, 10.1038/sj.bjp.0703101 · DOI
  151. Mialet, 2000, Pharmacological characterization of the human 5-HT4d receptor splice variant stably expressed in Chinese hamster ovary cells, Br J Pharmacol, 131, 827, 10.1038/sj.bjp.0703641 · DOI
  152. Middlemiss, 1990, The 5-HT1B receptors, Ann NY Acad Sci, 600, 132, 10.1111/j.1749-6632.1990.tb16878.x · DOI
  153. Middlemiss, 1999, SB-236057, a selective 5-HT1B receptor inverse agonist, blocks the 5-HT human terminal autoreceptor, Eur J Pharmacol, 375, 359, 10.1016/S0014-2999(99)00262-9 · DOI
  154. Millan, 1997, Potentiation of fluoxetine-induced penile erections by combined blockade of 5-HT1A and 5-HT1B receptors, Eur J Pharmacol, 321, R11, 10.1016/S0014-2999(97)00050-2 · doi:10.1016/s0014-2999(97)00050-2
  155. Millan, 1993, Induction of hypothermia as a model of 5-hydroxytryptamine 1A receptor-mediated activity in the rat A pharmacological characterization of the actions of novel agonists and antagonists, J Pharmacol Exp Ther, 264, 1364
  156. Millan, 1997, 5-HT2C receptors mediate penile erections in rats: actions of novel and selective agonists and antagonists, Eur J Pharmacol, 325, 9, 10.1016/S0014-2999(97)89962-1 · DOI
  157. Millan, 1998, Serotonin (5-HT) 2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo, Neuropharmacology, 37, 953, 10.1016/S0028-3908(98)00078-1 · DOI · Paper page
  158. Miller, 1992, Quantitative autoradiography of 5-CT-sensitive (5-HT1D) and 5-CT-insensitive (5-HT1E) serotonin receptors in human brain, Neurosci Lett, 136, 223, 10.1016/0304-3940(92)90054-B · DOI
  159. Miquel, 1995, Developmental changes in the differential expression of two serotonin 5-HT3 receptor splice variants in the rat, J Neurochem, 65, 475, 10.1046/j.1471-4159.1995.65020475.x · doi:10.1046/j.1471-4159.1995.65020475.x
  160. Mullins, 1999, Effects of antidepressants on 5-HT7 receptor regulation in the rat hypothalamus, Neuropsychopharmacology, 21, 352, 10.1016/S0893-133X(99)00041-X · DOI
  161. Newman-Tancredi, 1998, Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPγS binding study, Eur J Pharmacol, 355, 245, 10.1016/S0014-2999(98)00483-X · DOI · Paper page
  162. Nicholson, 2001, Anaesthetic-like interaction of the sleep-inducing lipid oleamide with voltage-gated sodium channels in mammalian brain, Anaesthesiology, 94, 120, 10.1097/00000542-200101000-00022 · DOI
  163. Niswender, 1999, RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity, J Biol Chem, 274, 9472, 10.1074/jbc.274.14.9472 · DOI · Paper page
  164. Niswender, 2001, RNA editing of the human serotonin 5-HT2C receptor alterations in suicide and implications for serotonergic pharmacotherapy, Neuropsychopharmacology, 24, 478, 10.1016/S0893-133X(00)00223-2 · DOI · Paper page
  165. Norman, 2000, Tegaserod, Novartis AG Current Opinion in Central and Phiphereral Nervous System Investigational Drugs, 2, 344
  166. Ohashi, 2001, Effects of 5-HT-moduline, a novel endogenous peptide, on serotonin release in the prefrontal cortex of freely moving rats, Biog Amines, 16, 101
  167. Ohmori, 2001, Novel polymorphism in the 5′-upstream region of the human 5-HT6 receptor gene and schizophrenia, Neurosci Lett, 310, 17, 10.1016/S0304-3940(01)02075-4 · doi:10.1016/s0304-3940(01)02075-4
  168. Parker, 1996, Allosteric modulation of 5-HT3 receptor: focus on alcohols and anaesthetic agents, Trends Pharmacol Sci, 17, 95, 10.1016/0165-6147(96)10003-1 · doi:10.1016/0165-6147(96)10003-1
  169. Parks, 1998, Increased anxiety of mice lacking the serotonin 1A receptor, Proc Natl Acad Sci U S A, 95, 10734, 10.1073/pnas.95.18.10734 · DOI · Paper page
  170. Pauwels, 1997, 5-HT1B/D receptor antagonists, Gen Pharmacol, 29, 293, 10.1016/S0306-3623(96)00460-0 · DOI
  171. Peroutka, 1979, Multiple serotonin receptors. Differential binding of [3H]-5-hydroxytryptamine, [3H]-lysergic acid diethylamide and [3H]-spiroperidol, Mol Pharmacol, 16, 687
  172. Phebus, 1997, Characterization of LY 344864 as a pharmacological tool to study 5-HT1F receptors: binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraine, Life Sci, 61, 2117, 10.1016/S0024-3205(97)00885-0 · DOI
  173. Pineyro, 1996, Autoregulatory properties of dorsal raphé 5-HT neurons: possible role of electrotonic coupling and 5-HT1D receptors in the rat brain, Synapse (N.Y.), 22, 54, 10.1002/(SICI)1098-2396(199601)22:1<54::AID-SYN6>3.0.CO;2-H · doi:10.1002/(sici)1098-2396(199601)22:1<54::aid-syn6>3.0.co;2-h
  174. Price, 1997, SB-216641 and BRL-15572: compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors, Naunyn-Schmiedeberg's Arch Pharmacol, 356, 312, 10.1007/PL00005056 · DOI · Paper page
  175. Raap, 1999, Selective serotonin reuptake inhibitors and neuroendocrine function, Life Sci, 65, 1217, 10.1016/S0024-3205(99)00169-1 · DOI
  176. Rahme, 1999, Electrophysiological and antiarrhythmic effects of the atrial selective 5-HT4 receptor antagonist RS-100302 in experimental atrial flutter and fibrillation, Circulation, 100, 2010, 10.1161/01.CIR.100.19.2010 · DOI
  177. Ramboz, 1995, 5-HT1B receptor knock out—behavioral consequences, Behav Brain Res, 73, 305, 10.1016/0166-4328(96)00119-2 · DOI · Paper page
  178. Reynolds, 1995, 5-Hydroxytryptamine (5-HT) 4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases, Br J Pharmacol, 114, 993, 10.1111/j.1476-5381.1995.tb13303.x · DOI · Paper page
  179. Risinger, 1999, Oral operant ethanol self-administration in 5-HT1b knockout mice, Behav Brain Res, 102, 211, 10.1016/S0166-4328(99)00012-1 · doi:10.1016/s0166-4328(99)00012-1
  180. Roberts, 2001, Interaction of serotonin autoreceptor antagonists in the rat dorsal raphe nucleus: an in vitro fast cyclic voltammetry study, Neurosci Lett, 300, 45, 10.1016/S0304-3940(01)01551-8 · DOI
  181. Roberts, 1997, Importance of h5-HT1B receptor selectivity for 5-HT terminal autoreceptor activity: an in vivo microdialysis study in the freely-moving guinea pig, Neuropharmacology, 36, 549, 10.1016/S0028-3908(97)00026-9 · doi:10.1016/s0028-3908(97)00026-9
  182. Roberts, 2000, The effect of SB-236057-A, a selective 5-HT1B receptor inverse agonist, on in vivo extracellular 5-HT levels in the freely-moving guinea-pig, Naunyn-Schmiedeberg's Arch Pharmacol, 362, 177, 10.1007/s002100000276 · DOI
  183. Roberts, 2001, The effect of SB-269970, a 5-HT7 receptor antagonist, on 5-HT release from serotonergic terminals and cell bodies, Br J Pharmacol, 132, 1574, 10.1038/sj.bjp.0703979 · DOI
  184. Ross, 1999, Robalzotan (NAD-299), a novel selective 5-HT1A receptor antagonist, CNS Drug Rev, 5, 213, 10.1111/j.1527-3458.1999.tb00101.x · doi:10.1111/j.1527-3458.1999.tb00101.x
  185. Roth, 1994, Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors, J Pharmacol Exp Ther, 268, 1403
  186. Rothman, 2000, Evidence for possible involvement of 5-HT2B receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications, Circulation, 102, 2836, 10.1161/01.CIR.102.23.2836 · DOI · Paper page
  187. Routledge, 2000, Characterization of SB-271046: a potent, selective and orally active 5-HT6 receptor antagonist, Br J Pharmacol, 130, 1606, 10.1038/sj.bjp.0703457 · DOI
  188. Ruat, 1993, Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation, Proc Nat Acad Sci U S A, 90, 8547, 10.1073/pnas.90.18.8547 · DOI · Paper page
  189. Saudou, 1994, Enhanced aggressive behavior in mice lacking 5-HT1B receptor, Science (Washington, D. C.), 265, 1875, 10.1126/science.8091214 · DOI · Paper page
  190. Schanen, 1996, Assignment of the 5-hydroxytryptamine (serotonin) receptor 5A gene (HTR5A) to human chromosome band 7q361, Cytogenet Cell Genet, 72, 187, 10.1159/000134184 · DOI
  191. Schlicker, 1997, Effects of selective h5-HT1B (SB-216641) and h5-HT1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptors, Naunyn-Schmiedeberg's Arch Pharmacol, 356, 321, 10.1007/PL00005057 · DOI
  192. Schreiber, 1995, (1-(2,5-Dimethoxy-4-iodophenyl) -2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists, J Pharmacol Exp Ther, 273, 101
  193. Sebben, 1994, 5-HT6 receptors positively coupled to adenylyl cyclase in striatal neurons in culture, NeuroReport, 5, 2553, 10.1097/00001756-199412000-00037 · DOI
  194. Selkirk, 1998, SB-224289: a novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activity, Br J Pharmacol, 125, 202, 10.1038/sj.bjp.0702059 · DOI
  195. Shen, 1993, Molecular cloning and expression of a 5-hydroxytryptamine 7 serotonin receptor subtype, J Biol Chem, 268, 18200, 10.1016/S0021-9258(17)46830-X · DOI · Paper page
  196. Sibella-Arguelles, 2001, The proliferation of human T lymphoblastic cells induced by 5-HT1B receptors activation is regulated by 5-HT-moduline, C R Acad Sci, Ser III, 324, 365, 10.1016/S0764-4469(00)01300-7 · doi:10.1016/s0764-4469(00)01300-7
  197. Sleight, 1995, Identification of 5-hydroxytryptamine7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment, Mol Pharmacol, 47, 99
  198. Sleight, 1998, Characterization of Ro 04-6790 and Ro 63-0563: potent and selective antagonists at human and rat 5-ht6 receptors, Br J Pharmacol, 124, 556, 10.1038/sj.bjp.0701851 · DOI · Paper page
  199. Thomas, 1997, Unique allosteric regulation of 5-hydroxytryptamine receptor-mediated signal transduction by oleamide, Proc Nat Acad Sci U S A, 94, 14115, 10.1073/pnas.94.25.14115 · DOI
  200. Thomas, 1998, Functional characterisation of the human cloned 5-HT7 receptor (long form); antagonist profile of SB 258719, Br J Pharmacol, 124, 1300, 10.1038/sj.bjp.0701946 · DOI

200 of 223 shown

Cited by

See all 1,865

Metadata

Authors
Hoyer, D., Hannon, J. P., & Martin, G. R.
Venue
Pharmacology Biochemistry and Behavior
Publisher
Elsevier BV
Published
2002-04
Volume
71
Issue
4
Pages
533-554
ISSN
0091-3057 (ISSN-L)
DOI
10.1016/s0091-3057(01)00746-8
OpenAlex
W2014001501
Cited by
1,865
References
3
FWCI
26.03
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Molecular, pharmacological and functional diversity of 5-HT receptors. https://app.cochat.ai/papers/10.1016/s0091-3057(01)00746-8
The paper
Hoyer, D., Hannon, J. P., & Martin, G. R. (2002). Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacology Biochemistry and Behavior. https://doi.org/10.1016/s0091-3057(01)00746-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.